We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following two other firms, Pfizer filed its own petitions with the PTO over a Herceptin patent owned by Genentech, as it continues to develop its biosimilar. Read More
The Department of Justice announced plans to review the Drug Enforcement Administration’s efforts to combat the spread of illegal opioid use through the agency’s enforcement actions against industry companies. Read More
FDA inspectors found extensive cleanliness and sterility issues during visits to California Pharmacy and Compounding Center in Newport Beach, Calif., in March and April. Read More
Ohio’s attorney general filed a lawsuit against Purdue Pharma, Endo Health Solutions, Teva, Johnson & Johnson and Allergan this week, alleging they contributed to the opioid epidemic through fraudulent advertising. Read More
The Supreme Court’s ruling this week on a patent dispute over printer toner cartridges could have wider effects on the pharmaceutical industry, international sales and product reimportation. Read More